Please enable JavaScript to continue using this application.

Compare $GRAL vs $MIRM | Chartloom

Compare

$GRAL vs $MIRM

Grail Inc · Mirum Pharmaceuticals Inc

GRAL

Grail Inc

MIRM

Mirum Pharmaceuticals Inc

Compare $GRAL vs $MIRM

Comparing Grail Inc and Mirum Pharmaceuticals Inc

GRALGrail Inc

MIRMMirum Pharmaceuticals Inc

GRALGrail Inc

Market cap

$6.03B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

29.71x

Rev growth (TTM)

23.1%

YTD performance

58.2%

52W performance

123.8%

FCF yield

-4.9%

MIRMMirum Pharmaceuticals Inc

Market cap

$5.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.85x

Rev growth (TTM)

44.0%

YTD performance

10.2%

52W performance

18.1%

FCF yield

-5.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GRAL

MIRM

Detailed metrics comparison

GRAL

Grail Inc

MIRM

Mirum Pharmaceuticals Inc

Market Cap

GRAL$6.03B

MIRM$5.24B

Enterprise Value

GRAL$5.98B

MIRM$5.66B

Price

GRAL$140.58

MIRM$86.01

P/E Ratio

GRALN/A

MIRMN/A

P/S Ratio

GRAL36.51x

MIRM8.49x

EV/Sales

GRAL36.17x

MIRM9.16x

EV/EBITDA

GRAL0.00x

MIRM2,753.41x

P/B Ratio

GRAL2.52x

MIRM22.21x

P/FCF Ratio

GRALN/A

MIRMN/A

EV/FCF

GRAL-20.19x

MIRM-21.48x

PEG Ratio

GRALN/A

MIRMN/A

Forward P/E (NTM)

GRALN/A

MIRMN/A

Forward P/S (NTM)

GRAL29.71x

MIRM6.85x

Revenue (TTM)

GRAL$165M

MIRM$618M

Revenue Growth (YoY)

GRAL23.1%

MIRM44.0%

Forward Rev Growth

GRAL25.3%

MIRM17.0%

Gross Margin (TTM)

GRAL49.7%

MIRM81.7%

Operating Margin (TTM)

GRAL0.0%

MIRM0.0%

EBITDA Margin (TTM)

GRAL-229.0%

MIRM-10.6%

Net Margin (TTM)

GRAL-236.9%

MIRM-139.2%

FCF Margin (TTM)

GRAL-179.2%

MIRM-42.7%

Net Income (TTM)

GRAL$-392M

MIRM$-860M

FCF (TTM)

GRAL$-296M

MIRM$-264M

EPS (TTM)

GRAL-$9.08

MIRM-$13.57

ROE (TTM)

GRAL-1588.0%

MIRM-28933.0%

ROA (TTM)

GRAL-1402.0%

MIRM-9655.0%

ROIC (TTM)

GRAL-1588.0%

MIRM-13639.0%

Cash

GRAL$56M

MIRM$331M

Debt

GRAL$0

MIRM$750M

Net Cash/Debt

GRAL$56M

MIRM$-419M

Current Ratio (TTM)

GRAL10.95x

MIRM2.86x

Quick Ratio (TTM)

GRAL10.55x

MIRM2.62x

Debt/Equity (TTM)

GRAL0.00x

MIRM1.28x

Debt/Assets (TTM)

GRAL0.0%

MIRM0.0%

Interest Coverage (TTM)

GRALN/A

MIRMN/A

Net Debt/EBITDA (TTM)

GRAL0.00x

MIRM0.00x

Beta

GRAL2.04

MIRM0.75

52W Performance

GRAL123.8%

MIRM18.1%

YTD Performance

GRAL58.2%

MIRM10.2%

% from 52W High

GRAL-15.6%

MIRM-33.8%

% from 52W Low

GRAL238.7%

MIRM36.0%

Asset Turnover (TTM)

GRAL0.06x

MIRM0.69x

FCF Yield (TTM)

GRAL-4.9%

MIRM-5.0%

Earnings Yield (TTM)

GRAL-6.5%

MIRM-16.4%

Dividend Yield (TTM)

GRALN/A

MIRMN/A

Rule of 40

GRAL-156.1

MIRM1.3

EV/GP/RG

GRAL2.75

MIRM0.45

Ticker research

View GRAL research View MIRM research

Metric	GRAL Grail Inc	MIRM Mirum Pharmaceuticals Inc
Market & Valuation
Market Cap	$6.03B	$5.24B
Enterprise Value	$5.98B	$5.66B
Price	$140.58	$86.01
P/E Ratio	N/A	N/A
P/S Ratio	36.51x	8.49x
EV/Sales	36.17x	9.16x
EV/EBITDA	0.00x	2,753.41x
P/B Ratio	2.52x	22.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-21.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	29.71x	6.85x
Revenue & Growth
Revenue (TTM)	$165M	$618M
Revenue Growth (YoY)	23.1%	44.0%
Forward Rev Growth	25.3%	17.0%
Profitability
Gross Margin (TTM)	49.7%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-229.0%	-10.6%
Net Margin (TTM)	-236.9%	-139.2%
FCF Margin (TTM)	-179.2%	-42.7%
Net Income (TTM)	$-392M	$-860M
FCF (TTM)	$-296M	$-264M
EPS (TTM)	-$9.08	-$13.57
ROE (TTM)	-1588.0%	-28933.0%
ROA (TTM)	-1402.0%	-9655.0%
ROIC (TTM)	-1588.0%	-13639.0%
Financial Health
Cash	$56M	$331M
Debt	$0	$750M
Net Cash/Debt	$56M	$-419M
Current Ratio (TTM)	10.95x	2.86x
Quick Ratio (TTM)	10.55x	2.62x
Debt/Equity (TTM)	0.00x	1.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.04	0.75
52W Performance	123.8%	18.1%
YTD Performance	58.2%	10.2%
% from 52W High	-15.6%	-33.8%
% from 52W Low	238.7%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.69x
FCF Yield (TTM)	-4.9%	-5.0%
Earnings Yield (TTM)	-6.5%	-16.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-156.1	1.3
EV/GP/RG	2.75	0.45
Ticker research	View GRAL research	View MIRM research

Valuation

P/S Ratio

MIRM

8.49x

GRAL

36.51x

EV/FCF

MIRM

-21.48x

GRAL

-20.19x

Growth & revenue

Revenue Growth TTM

MIRM

44.0%

GRAL

23.1%

Forward Revenue Growth

GRAL

25.3%

MIRM

17.0%

Profitability & performance

Gross Margin

MIRM

81.7%

GRAL

49.7%

ROE

GRAL

-1588.0%

MIRM

-28933.0%

FCF Yield %

GRAL

-4.9%

MIRM

-5.0%

52-Week Performance

GRAL

123.8%

MIRM

18.1%

Detailed metrics comparison

GRAL

Grail Inc

MIRM

Mirum Pharmaceuticals Inc

Market Cap

GRAL$6.03B

MIRM$5.24B

Enterprise Value

GRAL$5.98B

MIRM$5.66B

Price

GRAL$140.58

MIRM$86.01

P/E Ratio

GRALN/A

MIRMN/A

P/S Ratio

GRAL36.51x

MIRM8.49x

EV/Sales

GRAL36.17x

MIRM9.16x

EV/EBITDA

GRAL0.00x

MIRM2,753.41x

P/B Ratio

GRAL2.52x

MIRM22.21x

P/FCF Ratio

GRALN/A

MIRMN/A

EV/FCF

GRAL-20.19x

MIRM-21.48x

PEG Ratio

GRALN/A

MIRMN/A

Forward P/E (NTM)

GRALN/A

MIRMN/A

Forward P/S (NTM)

GRAL29.71x

MIRM6.85x

Revenue (TTM)

GRAL$165M

MIRM$618M

Revenue Growth (YoY)

GRAL23.1%

MIRM44.0%

Forward Rev Growth

GRAL25.3%

MIRM17.0%

Gross Margin (TTM)

GRAL49.7%

MIRM81.7%

Operating Margin (TTM)

GRAL0.0%

MIRM0.0%

EBITDA Margin (TTM)

GRAL-229.0%

MIRM-10.6%

Net Margin (TTM)

GRAL-236.9%

MIRM-139.2%

FCF Margin (TTM)

GRAL-179.2%

MIRM-42.7%

Net Income (TTM)

GRAL$-392M

MIRM$-860M

FCF (TTM)

GRAL$-296M

MIRM$-264M

EPS (TTM)

GRAL-$9.08

MIRM-$13.57

ROE (TTM)

GRAL-1588.0%

MIRM-28933.0%

ROA (TTM)

GRAL-1402.0%

MIRM-9655.0%

ROIC (TTM)

GRAL-1588.0%

MIRM-13639.0%

Cash

GRAL$56M

MIRM$331M

Debt

GRAL$0

MIRM$750M

Net Cash/Debt

GRAL$56M

MIRM$-419M

Current Ratio (TTM)

GRAL10.95x

MIRM2.86x

Quick Ratio (TTM)

GRAL10.55x

MIRM2.62x

Debt/Equity (TTM)

GRAL0.00x

MIRM1.28x

Debt/Assets (TTM)

GRAL0.0%

MIRM0.0%

Interest Coverage (TTM)

GRALN/A

MIRMN/A

Net Debt/EBITDA (TTM)

GRAL0.00x

MIRM0.00x

Beta

GRAL2.04

MIRM0.75

52W Performance

GRAL123.8%

MIRM18.1%

YTD Performance

GRAL58.2%

MIRM10.2%

% from 52W High

GRAL-15.6%

MIRM-33.8%

% from 52W Low

GRAL238.7%

MIRM36.0%

Asset Turnover (TTM)

GRAL0.06x

MIRM0.69x

FCF Yield (TTM)

GRAL-4.9%

MIRM-5.0%

Earnings Yield (TTM)

GRAL-6.5%

MIRM-16.4%

Dividend Yield (TTM)

GRALN/A

MIRMN/A

Rule of 40

GRAL-156.1

MIRM1.3

EV/GP/RG

GRAL2.75

MIRM0.45

Ticker research

View GRAL research View MIRM research

Metric	GRAL Grail Inc	MIRM Mirum Pharmaceuticals Inc
Market & Valuation
Market Cap	$6.03B	$5.24B
Enterprise Value	$5.98B	$5.66B
Price	$140.58	$86.01
P/E Ratio	N/A	N/A
P/S Ratio	36.51x	8.49x
EV/Sales	36.17x	9.16x
EV/EBITDA	0.00x	2,753.41x
P/B Ratio	2.52x	22.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-21.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	29.71x	6.85x
Revenue & Growth
Revenue (TTM)	$165M	$618M
Revenue Growth (YoY)	23.1%	44.0%
Forward Rev Growth	25.3%	17.0%
Profitability
Gross Margin (TTM)	49.7%	81.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-229.0%	-10.6%
Net Margin (TTM)	-236.9%	-139.2%
FCF Margin (TTM)	-179.2%	-42.7%
Net Income (TTM)	$-392M	$-860M
FCF (TTM)	$-296M	$-264M
EPS (TTM)	-$9.08	-$13.57
ROE (TTM)	-1588.0%	-28933.0%
ROA (TTM)	-1402.0%	-9655.0%
ROIC (TTM)	-1588.0%	-13639.0%
Financial Health
Cash	$56M	$331M
Debt	$0	$750M
Net Cash/Debt	$56M	$-419M
Current Ratio (TTM)	10.95x	2.86x
Quick Ratio (TTM)	10.55x	2.62x
Debt/Equity (TTM)	0.00x	1.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.04	0.75
52W Performance	123.8%	18.1%
YTD Performance	58.2%	10.2%
% from 52W High	-15.6%	-33.8%
% from 52W Low	238.7%	36.0%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.69x
FCF Yield (TTM)	-4.9%	-5.0%
Earnings Yield (TTM)	-6.5%	-16.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-156.1	1.3
EV/GP/RG	2.75	0.45
Ticker research	View GRAL research	View MIRM research